Rotigotine transdermal patch in Chinese patients with advanced Parkinson's disease: A randomized, double-blind, placebo-controlled pivotal study.

Author: AsgharnejadMahnaz, BauerLars, LiuChun-Feng, LiuYi-Ming, ShaoMing, SurmannErwin, TaoEn-Xiang, WangJian, XueHai-Bo, ZhangZhen-Xin

Paper Details 
Original Abstract of the Article :
Rotigotine was demonstrated to be efficacious and well-tolerated in three placebo-controlled studies (CLEOPATRA-PD/PREFER/SP921) of patients with advanced-stage Parkinson's disease (PD), most of whom were Caucasian. This multicenter phase 3 study (SP1037; NCT01646255) was the first to investigate th...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.parkreldis.2017.08.015

データ提供:米国国立医学図書館(NLM)

Rotigotine for Parkinson's Disease: A New Oasis in the Desert of Movement Disorders

Parkinson's disease is a challenging condition, often likened to navigating a vast and unforgiving desert. This research, conducted in China, explores the effectiveness of rotigotine, a medication delivered through a transdermal patch, in treating advanced-stage Parkinson's disease. The study aimed to understand if rotigotine could offer relief to patients in a region with a unique demographic profile. While rotigotine's efficacy had been established in previous studies, this was the first investigation of its impact on Chinese patients.

A Beacon of Hope in the Desert: Rotigotine for Chinese Patients with Parkinson's Disease

The study concluded that rotigotine was effective and well-tolerated in Chinese patients with advanced-stage Parkinson's disease. This discovery is like finding a wellspring of relief in the desert, providing a potential treatment option for a growing population of patients. These results are encouraging, highlighting the potential for rotigotine to be a valuable tool in managing Parkinson's disease across diverse populations.

Finding a Path Through the Desert: Living with Parkinson's Disease

Living with Parkinson's disease can feel like traversing a vast and often unpredictable desert. Research like this provides valuable insights into new treatment options, offering hope for a more manageable journey. It is important to remember that each individual's experience with Parkinson's disease is unique, and finding the right treatment path requires careful consideration and collaboration with healthcare professionals. This study reminds us that ongoing research is crucial in uncovering new solutions to this complex condition.

Dr.Camel's Conclusion

This research offers a glimmer of hope in the vast desert of Parkinson's disease, demonstrating rotigotine's potential to benefit a diverse population. Like a traveler finding a hidden oasis, patients with Parkinson's disease may discover relief and improved quality of life through this medication. While more research is needed to fully understand its long-term effects, this study provides a promising starting point for managing this complex condition.

Date :
  1. Date Completed 2018-07-27
  2. Date Revised 2022-12-07
Further Info :

Pubmed ID

28827011

DOI: Digital Object Identifier

10.1016/j.parkreldis.2017.08.015

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.